Clinical trial
Islet Allotransplantation With Steroid Free Immunosuppression
NCT00446264 · University Hospital, Lille, Other · Completed
Key facts
| NCT number | NCT00446264 |
|---|---|
| Title | Islet Allotransplantation With Steroid Free Immunosuppression |
| Official title | Sequential Islet Transplantation With Steroid Free Immunosuppression for Type 1 Diabetes |
| Lead sponsor | University Hospital, Lille, Other |
| Collaborators | Institut National de la Santé Et de la Recherche Médicale, France |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes, Hypoglycemia, Metabolic Diseases |
| Intervention type | Drug, Procedure |
| Interventions | islet transplantation, daclizumab - sirolimus - tacrolimus |
| Enrollment | 14 |
| Start date | May 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Feb 1, 2009 |
| First posted | Mar 12, 2007 |
| Last update posted | Apr 27, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: